My Companies
Notification
Account
Log Out
Login
Gujarat Themis Biosyn closed its QIP, approving the issue of 2.12 crore equity shares to QIBs at ₹354 each, a 4.98% discount to the ₹372.57 floor price, raising approximately ₹75 crore. Context: first funding step toward the acquisition program.
Gujarat Themis Biosyn Completes JPY 21.5 Billion MicroBiopharm Japan Acquisition
Gujarat Themis Biosyn Allots Rs 585 Crore NCDs To Fund MBJ Acquisition
Gujarat Themis Biosyn Approves ₹585 Crore Unlisted NCD Programme
Gujarat Themis Biosyn Board Approves ₹335 Crore Preferential Share Issue
Gujarat Themis Biosyn Opens QIP At ₹372.57 Floor Price